Forbes contributors publish independent expert analyses and insights. Robert Glatter is a New York-based physician covering public health. When a healthcare provider writes a prescription for a ...

Oracle has expanded its move into pharmaceutical innovation by investing an undisclosed “minor” sum in Proteus Digital Health, a company that has developed ingestible and wearable sensors. Proteus’ ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Proteus Digital Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its ingestible sensor for marketing as a medical device ...

Proteus Digital Health could exit bankruptcy in a deal with Otsuka Pharmaceutical, one of its main customers. Proteus, founded in 2001, develops ingestible sensors and a wearable sensor patch to track ...

REDWOOD CITY, Calif. – July 30, 2012 – Proteus Digital Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its ingestible sensor for marketing as a medical device ...

Proteus’s sensors attach to the pills patients swallow-and then tell doctors how their bodies respond.. Yudi Ela; Prop styling: Astrid Chastka/Hello Artists Many people forget to take their pills or ...

Digital medicine company Proteus Digital Health has raised an additional $52 million from undisclosed investors following a whopping $120 million raise the company announced just last month. That ...

Otsuka Pharmaceutical and Proteus Digital Health re-submitted an FDA application for their chip-in-a-pill, which combines antipsychotic Abilify with an ingestible sensor made by Proteus. The FDA is ...